Travoprost
Travoprost, sold under the brand name Travatan among others, is a medication used to treat high pressure inside the eye including glaucoma. Specifically it is used for open angle glaucoma when other agents are not sufficient. It is used as an eye drop. Effects generally occur within two hours.
Clinical data | |
---|---|
Trade names | Travatan, Izba, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a602027 |
License data |
|
Pregnancy category |
|
Routes of administration | Topical eye drops |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Metabolism | Activation by ester hydrolysis, deactivation by beta oxidation, OH-oxidation, double bond reduction |
Onset of action | 2 hours |
Elimination half-life | 1.5 hours (in aqueous fluid) 45 minutes (terminal) |
Duration of action | ≥ 24 hours |
Excretion | Mainly via kidney |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.207.141 |
Chemical and physical data | |
Formula | C26H35F3O6 |
Molar mass | 500.555 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Common side effects include red eyes, blurry vision, eye pain, dry eyes, and change in color of the eyes. Other significant side effects may include cataracts. Use during pregnancy or breastfeeding is generally not recommended. It is a prostaglandin analog and works by increasing the outflow of aqueous fluid from the eyes.
Travoprost was approved for medical use in the United States and in the European Union in 2001. It is available as a generic medication in the United Kingdom. In 2020, it was the 304th most commonly prescribed medication in the United States, with more than 1 million prescriptions.